HIT diagnostic
production of GAG glycan arrays
GAG arrays production
GAG glycan microarrays
complex of heparin
administration of heparin
Heparin-induced thrombocytopenia
Synthetic Glycosaminoglycans Heparin
Inexpensive Diagnosis of Heparin Induced Thrombocytopenia
effect of heparin administration
printing GAG oligosaccharides
Specific glycan markers of high diagnostic value
Synthetic Glycosaminoglycans Rapid
business plan
low diagnostic specificity
company
patients
complex glycosaminoglycan
potential customers
potential markets
IP strategy
IP space
major surgery
MAIPA tests
business model
existing tests
Specific activities
patient wellbeing
patient blood
used anticoagulant
cardiopulmonary bypass surgery
Development of standard protocols
automated assembly of defined oligosaccharides
deep-vein thrombosis
instrument
results
infarction
basis
acute coronary syndrome
Analysis
commercial discussion
multi-organ failure
cost structure
conditions
dialysis
complications
surfaces
antibodies
platelet factor
ERC Advanced grant AUTOHEPARIN
project
cheaper methods
investors
minutes
reliabilities
carbohydrate
mortality
HIPA
accuracy
discussions
overall goal
costs
diagnostics
Europe